Neonatal outcomes following introduction of routine probiotic supplementation to very preterm infants

Abstract

AbstractAimTo evaluate the combined outcome of death and/or severe grade necrotising enterocolitis (NEC) in very preterm infants admitted to Cork University Maternity Hospital, Ireland, before and after introduction of routine supplementation with Bifidobacterium bifidum and Lactobacillus acidophilus probiotics (Infloran®).MethodsA retrospective study of infants <32 weeks gestation and < 1500 g surviving beyond 72 h of life was performed. Two 6‐year epochs; pre‐probiotics (Epoch 1: 2008–2013) and with probiotics (Epoch 2: 2015–2020), were evaluated. The primary outcome was defined as death after 72 h or NEC Bell stage 2a or greater.ResultsSeven‐hundred‐and‐forty‐four infants were included (Epoch 1: 391, Epoch 2: 353). The primary outcome occurred in 67 infants (Epoch 1: 37, Epoch 2: 30, p = 0.646). After adjustment, the difference was significant (OR [95% CI]: 0.53 [0.29 to 0.97], p = 0.038). Differences between epochs did not depend on gestational age group (<28 weeks; ≥28 weeks).ConclusionThere was an associated reduction of the composite outcome of severe grade NEC and/or death, after adjustment for confounding variables, with introduction of routine administration of a B. bifidum and L. acidophilus probiotic at our institution.